These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 9850177)

  • 1. Follicular and Hurthle cell carcinomas of the thyroid: a comparative study.
    Evans HL; Vassilopoulou-Sellin R
    Am J Surg Pathol; 1998 Dec; 22(12):1512-20. PubMed ID: 9850177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathologic study and clinical significance of Hürthle cell papillary thyroid carcinoma.
    Mai KT; Thomas J; Yazdi HM; Commons AS; Lamba M; Stinson AW
    Appl Immunohistochem Mol Morphol; 2004 Dec; 12(4):329-37. PubMed ID: 15536332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thyroid follicular carcinoma: sonographic features of 50 cases.
    Sillery JC; Reading CC; Charboneau JW; Henrichsen TL; Hay ID; Mandrekar JN
    AJR Am J Roentgenol; 2010 Jan; 194(1):44-54. PubMed ID: 20028904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Follicular and Hürthle cell carcinoma: predicting outcome and directing therapy.
    Sanders LE; Silverman M
    Surgery; 1998 Dec; 124(6):967-74. PubMed ID: 9854570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic impact of extent of vascular invasion in low-grade encapsulated follicular cell-derived thyroid carcinomas: a clinicopathologic study of 276 cases.
    Xu B; Wang L; Tuttle RM; Ganly I; Ghossein R
    Hum Pathol; 2015 Dec; 46(12):1789-98. PubMed ID: 26482605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differentiated thyroid carcinomas with vascular invasion: a comparative study of follicular, Hürthle cell and papillary thyroid carcinoma.
    Mai KT; Khanna P; Yazdi HM; Perkins DG; Veinot JP; Thomas J; Lamba M; Nair BD
    Pathology; 2002 Jun; 34(3):239-44. PubMed ID: 12109784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Poorly differentiated oncocytic (hürthle cell) follicular carcinoma: an institutional experience.
    Bai S; Baloch ZW; Samulski TD; Montone KT; LiVolsi VA
    Endocr Pathol; 2015 May; 26(2):164-9. PubMed ID: 25898815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Encapsulated Thyroid Carcinoma of Follicular Cell Origin.
    Xu B; Ghossein R
    Endocr Pathol; 2015 Sep; 26(3):191-9. PubMed ID: 26003547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic factors in patients with Hürthle cell neoplasms of the thyroid.
    Lopez-Penabad L; Chiu AC; Hoff AO; Schultz P; Gaztambide S; Ordoñez NG; Sherman SI
    Cancer; 2003 Mar; 97(5):1186-94. PubMed ID: 12599224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does Hürthle cell carcinoma of the thyroid have a poorer prognosis than ordinary follicular thyroid carcinoma?
    Sugino K; Kameyama K; Ito K; Nagahama M; Kitagawa W; Shibuya H; Ohkuwa K; Uruno T; Akaishi J; Suzuki A; Masaki C; Ito K
    Ann Surg Oncol; 2013 Sep; 20(9):2944-50. PubMed ID: 23616135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Follicular carcinoma of the thyroid.
    Segal K; Arad A; Lubin E; Shpitzer T; Hadar T; Feinmesser R
    Head Neck; 1994; 16(6):533-8. PubMed ID: 7822175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Death from thyroid cancer of follicular cell origin.
    Wu HS; Young MT; Ituarte PH; D'Avanzo A; Duh QY; Greenspan FS; Loh KC; Clark OH
    J Am Coll Surg; 2000 Dec; 191(6):600-6. PubMed ID: 11129807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinicopathologic Features of Fatal Non-Anaplastic Follicular Cell-Derived Thyroid Carcinomas.
    Xu B; Ibrahimpasic T; Wang L; Sabra MM; Migliacci JC; Tuttle RM; Ganly I; Ghossein R
    Thyroid; 2016 Nov; 26(11):1588-1597. PubMed ID: 27480016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does Hurthle cell lesion/neoplasm predict malignancy more than follicular lesion/neoplasm on thyroid fine-needle aspiration?
    Pu RT; Yang J; Wasserman PG; Bhuiya T; Griffith KA; Michael CW
    Diagn Cytopathol; 2006 May; 34(5):330-4. PubMed ID: 16604553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathological tumor-node-metastasis (pTNM) staging for papillary and follicular thyroid carcinomas: a retrospective analysis of 700 patients.
    Loh KC; Greenspan FS; Gee L; Miller TR; Yeo PP
    J Clin Endocrinol Metab; 1997 Nov; 82(11):3553-62. PubMed ID: 9360506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Follicular neoplasms of the thyroid. A study of 44 cases followed for a minimum of 10 years, with emphasis on differential diagnosis.
    Evans HL
    Cancer; 1984 Aug; 54(3):535-40. PubMed ID: 6733684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of follicular and Hürthle cell neoplasms of the thyroid gland.
    McHenry CR; Sandoval BA
    Surg Oncol Clin N Am; 1998 Oct; 7(4):893-910. PubMed ID: 9735140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic factors of recurrence in encapsulated Hurthle cell carcinoma of the thyroid gland: a clinicopathologic study of 50 cases.
    Ghossein RA; Hiltzik DH; Carlson DL; Patel S; Shaha A; Shah JP; Tuttle RM; Singh B
    Cancer; 2006 Apr; 106(8):1669-76. PubMed ID: 16534796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic factors of follicular thyroid carcinoma.
    Ríos A; Rodríguez JM; Ferri B; Martínez-Barba E; Torregrosa NM; Parrilla P
    Endocrinol Nutr; 2015 Jan; 62(1):11-8. PubMed ID: 25156926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Poorly differentiated thyroid carcinomas defined on the basis of mitosis and necrosis: a clinicopathologic study of 58 patients.
    Hiltzik D; Carlson DL; Tuttle RM; Chuai S; Ishill N; Shaha A; Shah JP; Singh B; Ghossein RA
    Cancer; 2006 Mar; 106(6):1286-95. PubMed ID: 16470605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.